Xenotransplantation
This article was originally published in The Gray Sheet
Executive Summary
Recipients of xenotransplantation products "should be deferred from donation of whole blood, blood components" and other body products, according to a revision issued Oct. 18 to the 1996 Draft PHS Guidelines on Infectious Disease Issues in Xenotransplantation. The revised document, which expands the definition of xenotransplantation from "live cells, tissues, or organs from a nonhuman animal source" to include "human body fluids, cells, tissues or organs that have had ex vivo contact with live nonhuman cells, tissues, or organs," is available online (http://www.fda.gov/cber/gdlns/xenophs1000.htm)